Literature DB >> 24627378

Risks of untreated depression in pregnancy.

Justin Chan, Aniket Natekar, Adrienne Einarson, Gideon Koren.   

Abstract

QUESTION: In my family practice, I tell my female patients of reproductive age who have depression that untreated depression in pregnancy might be more harmful than the unproven risks of antidepressants. However, I recently read in a national news magazine that there is actually no evidence for this advice. Have I missed something? ANSWER: You did not miss anything, so you should continue to advise your pregnant patients as before. News magazines can have substantial bias, as the reporters often only interview "experts" who support their beliefs, as was probably the case in this article. Most glaringly, in this instance, no perinatal psychiatrists were interviewed and none of the experts were clinically involved with pregnant women. We believe that media statements like the one you mentioned might lead women to abruptly discontinue their antidepressants, putting themselves at risk of relapse, hospitalization, and even suicide. Your balancing role in providing your patient with evidence-based information is critical.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24627378      PMCID: PMC3952758     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN: 0008-350X            Impact factor:   3.275


  12 in total

Review 1.  Antidepressant use during pregnancy: the benefit-risk ratio.

Authors:  Gideon Koren; Hedvig Nordeng
Journal:  Am J Obstet Gynecol       Date:  2012-02-21       Impact factor: 8.661

Review 2.  Perinatal risks of untreated depression during pregnancy.

Authors:  Lori Bonari; Natasha Pinto; Eric Ahn; Adrienne Einarson; Meir Steiner; Gideon Koren
Journal:  Can J Psychiatry       Date:  2004-11       Impact factor: 4.356

3.  Neurodevelopment of children exposed in utero to antidepressant drugs.

Authors:  I Nulman; J Rovet; D E Stewart; J Wolpin; H A Gardner; J G Theis; N Kulin; G Koren
Journal:  N Engl J Med       Date:  1997-01-23       Impact factor: 91.245

4.  Relapse of major depression during pregnancy in women who maintain or discontinue antidepressant treatment.

Authors:  Lee S Cohen; Lori L Altshuler; Bernard L Harlow; Ruta Nonacs; D Jeffrey Newport; Adele C Viguera; Rita Suri; Vivien K Burt; Victoria Hendrick; Alison M Reminick; Ada Loughead; Allison F Vitonis; Zachary N Stowe
Journal:  JAMA       Date:  2006-02-01       Impact factor: 56.272

5.  Role of anxiety and depression in the onset of spontaneous preterm labor.

Authors:  J Dayan; C Creveuil; M Herlicoviez; C Herbel; E Baranger; C Savoye; A Thouin
Journal:  Am J Epidemiol       Date:  2002-02-15       Impact factor: 4.897

6.  Implications of antenatal depression and anxiety for obstetric outcome.

Authors:  Liselott Andersson; Inger Sundström-Poromaa; Marianne Wulff; Monica Aström; Marie Bixo
Journal:  Obstet Gynecol       Date:  2004-09       Impact factor: 7.661

7.  Depressive symptoms during pregnancy: relationship to poor health behaviors.

Authors:  B Zuckerman; H Amaro; H Bauchner; H Cabral
Journal:  Am J Obstet Gynecol       Date:  1989-05       Impact factor: 8.661

8.  Psychological health in early pregnancy: relationship with nausea and vomiting.

Authors:  B L Swallow; S W Lindow; E A Masson; D M Hay
Journal:  J Obstet Gynaecol       Date:  2004-01       Impact factor: 1.246

Review 9.  The management of depression during pregnancy: a report from the American Psychiatric Association and the American College of Obstetricians and Gynecologists.

Authors: 
Journal:  Obstet Gynecol       Date:  2009-09       Impact factor: 7.661

10.  Depression during Pregnancy : Overview of Clinical Factors.

Authors:  Heather A Bennett; Adrienne Einarson; Anna Taddio; Gideon Koren; Thomas R Einarson
Journal:  Clin Drug Investig       Date:  2004       Impact factor: 2.859

View more
  8 in total

1.  Selective serotonin reuptake inhibitor discontinuation during pregnancy: at what risk?

Authors:  Resham Ejaz; Tom Leibson; Gideon Koren
Journal:  Can Fam Physician       Date:  2014-12       Impact factor: 3.275

Review 2.  [Affective disorders during pregnancy : Therapy with antidepressants and mood stabilizers].

Authors:  N Bergemann; W E Paulus
Journal:  Nervenarzt       Date:  2016-09       Impact factor: 1.214

Review 3.  [Psychopharmacotherapy during pregnancy : Which antipsychotics, tranquilizers and hypnotics are suitable?].

Authors:  N Bergemann; W E Paulus
Journal:  Nervenarzt       Date:  2016-09       Impact factor: 1.214

4.  Untreated depression in the first trimester of pregnancy leads to postpartum depression: high rates from a natural follow-up study.

Authors:  Esra Yazici; Tulay Sati Kirkan; Puren Akcali Aslan; Nazan Aydin; Ahmet Bulent Yazici
Journal:  Neuropsychiatr Dis Treat       Date:  2015-02-19       Impact factor: 2.570

Review 5.  Efficacy and Safety of Transcranial Electric Stimulation during the Perinatal Period: A Systematic Literature Review and Three Case Reports.

Authors:  Andrew Laurin; Noémie Nard; Marine Dalmont; Samuel Bulteau; Cloé Bénard; Olivier Bonnot; Norbert Winer; Françoise Dupont; Gisèle Apter; Frédérique Terranova-Commessie; Olivier Guillin; Wissam El-Hage; Anne Sauvaget; Maud Rothärmel
Journal:  J Clin Med       Date:  2022-07-13       Impact factor: 4.964

6.  Safety of deep brain stimulation in pregnancy: A comprehensive review.

Authors:  Caroline King; T Maxwell Parker; Kay Roussos-Ross; Adolfo Ramirez-Zamora; John C Smulian; Michael S Okun; Joshua K Wong
Journal:  Front Hum Neurosci       Date:  2022-09-29       Impact factor: 3.473

7.  The Effect of Mindfulness-integrated Cognitive Behavior Therapy on Depression and Anxiety among Pregnant Women: a Randomized Clinical Trial.

Authors:  Reza Yazdanimehr; Abdollah Omidi; Zohreh Sadat; Hossein Akbari
Journal:  J Caring Sci       Date:  2016-09-01

8.  Affective Instability, Depression, and Anxiety Symptoms in a Community Sample of Pregnant and Postpartum Women: A Cross-Sectional Study.

Authors:  Hua Li
Journal:  Int J Environ Res Public Health       Date:  2022-03-08       Impact factor: 3.390

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.